| Metric | FY 2026 | FY 2025 |
|---|---|---|
| Revenue | 0.1 | — |
| Profit before tax | -6.3 | -1.1 |
| Net income | 6.7 | -3.3 |
| EPS (diluted, $ a share) | $5.33 | $-3.18 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
10-K filed with the SEC, NASDAQ: ADVB. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
Advanced Biomed Inc.: key numbers
- Share price
- $2.22Close, Nov 16
- Market cap
- $3.67M
- Shares outstanding
- 1.65MLatest SEC cover page
- Sector
- Industrial Applications and Services
- Industry
- Services-Medical LaboratoriesSIC 8071
Today's reference numbers, updated daily. Not a valuation or a recommendation.
More from Advanced Biomed Inc.
All →Advanced Biomed Q1 2026 Results: Net Loss of $989K, Loss Widens
Advanced Biomed Inc. reported a net loss of $989,054 for the quarter ended September 30, 2026, as it transitioned from biotechnology to AI and financial software activities. The company's cash position decreased to $213,995, and it recognized a significant provision for credit losses of $612,636 during the period.
- Key figure
- Net loss $989K